Author

T. H. Kang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Iniguez· 1 shared C. Kim· 1 shared D. J. Diamond· 1 shared E. Kang· 1 shared E. Park· 1 shared E. R. Manuel· 1 shared F. Chiuppesi· 1 shared F. Wussow· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Iniguez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ACCELERATING ANTIBODY DESIGN WITH ACTIVE LEARNING

S.-w. Seo, M. W. Kwak, E. Kang, C. Kim, E. Park, T. H. Kang, J. Kim

The paper develops a sequence generation model using transfer and active learning to efficiently discover binding antibodies with novel HCDR3 regions, requiring only six thousand data points per antigen.

bioRxiv · Sep 12, 2022 · PreprintBioengineering

Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine

F. Chiuppesi, M. S. Werner, H. Contreras, H. V. Nguyen, J. Martinez, S. Park, J. Nguyen, M. Kha, A. Iniguez, Q. Zhou, T. Kaltcheva, R. Levytskyy, N. D. Ebelt, T. H. Kang, X. Wu, , F. Wussow

This paper develops a synthetic DNA-based vaccine platform to rapidly generate SARS-CoV-2 vaccines using recombinant MVA vectors expressing spike and nucleocapsid antigens, showing robust immune responses in mice.

bioRxiv · Jul 1, 2020 · PreprintImmunology